160 likes | 426 Views
Buruli Ulcer . Arwen Frick-Cheng Bio 402. What is Buruli Ulcer?. Infectious disease Characterized by the WHO as a Neglected Tropical Diseases (NTD) 14 NTD Widely disregarded by industrial nations. What is Buruli Ulcer?. Regions/People Affected. Tropical wetlands and rainforest
E N D
Buruli Ulcer Arwen Frick-Cheng Bio 402
What is Buruli Ulcer? • Infectious disease • Characterized by the WHO as a Neglected Tropical Diseases (NTD) • 14 NTD • Widely disregarded by industrial nations
Regions/People Affected • Tropical wetlands and rainforest • Mainly: West and Central Africa • Associated with bodies of stagnant water • The immunocompromised • The poor • Children
Causative Agent • Mycobacterium ulcerans • Related to Tuberculosis, Leprosy Colonies of Mycobacterium ulcerans. http://www.public.asu.edu/~shaydel/research_002buruli.html
Identification of Bacteria • Acid Fast Stain • Selective Culture • Histopathology • PCR Acid-fast stain of Mycobacterium ulcerans. http://www.who.int/buruli/information/diagnosis/en/index14.html
Symptoms • Long latent period • Usually on exposed body parts • Four stages
Virulence Factor • Toxin: Mycolactone • Immunosupressant • Necrosis
Treatment • Antibiotic • Rifampicin • Surgical removal/amputation • Vaccination (BCG) • Alternatives • Heat treatment • French Clay • Topical nitrogen oxides • Will slowly heal on its own
Effects • Heavy scarring • Contracture of limbs • Blindness • secondary infections
References • Neglected Diseases Caused By Bacterial Infections. M. Bechtle, S. Chen and T. Efferth. Current Medicinal Chemistry, 2010, 17, 42-60 • Laboratory diagnosis of Buruli ulcer disease. Marcus Beissner, Karl-Heinz Herbinger & Gisela Bretzel. Future Science Group • MycolactoneInhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism.Rachel E. Simmonds et al. J. Immunol. 2009;182;2194-2202